Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

389
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
389
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

499
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
499
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

829
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
829
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

354
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
354
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

727
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
727
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

886
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
886

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stakeholders Want a Menu of Choices: Findings from a Consultation Workshop on Improving Access to Secondary Prophylaxis of Rheumatic Fever and Rheumatic Heart Disease.

Global heart·2026
Same author

Comparative evaluation of performance and precision of multiplex immunoassays measuring human IgG to <i>Streptococcus pyogenes</i> vaccine antigens.

Frontiers in immunology·2026
Same author

CXCR3 is associated with T-cell-induced heart damage in acute rheumatic fever.

Nature communications·2026
Same author

Acute Rheumatic Fever Diagnostic Network (ARC Network) clinical recruitment protocol.

BMJ open·2026
Same author

Distance from tertiary care, pericardial effusion, and nutritional status predict all-cause mortality among Malawian children with rheumatic heart disease.

medRxiv : the preprint server for health sciences·2026
Same author

Early rheumatic heart disease is a recognized intermediate on the pathway to advanced rheumatic heart disease.

International journal of cardiology·2026
Same journal

Identification of an early-formed HIV-1 circulating recombinant form (CRF202_BC) in the southern border region of Yunnan, China.

The Journal of infection·2026
Same journal

Streptococcus agalactiae bone and joint infection: a multicentre observational study 2014-23.

The Journal of infection·2026
Same journal

Respiratory viral detection in adult severe acute respiratory infection post-COVID-19 pandemic: implications for antimicrobial stewardship.

The Journal of infection·2026
Same journal

Home-Based Rapid Testing and Early Antiviral Treatment as a Potential Strategy to Blunt Pediatric Influenza Peak.

The Journal of infection·2026
Same journal

Landscape and ecological correlates of tick-associated viruses in Inner Mongolia, China.

The Journal of infection·2026
Same journal

Age-associated impairment of humoral and cellular immune responses to SARS-CoV-2 in a large community cohort with hybrid immunity.

The Journal of infection·2026
See all related articles

Related Experiment Video

Updated: Apr 14, 2026

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis
14:54

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis

Published on: January 27, 2019

12.0K

Pediatric sepsis in the developing world.

Niranjan Kissoon1, Jonathan Carapetis2

  • 1Global Child Health, Department of Pediatrics and Emergency Medicine, University of British Columbia, Vancouver V6H 3V4, Canada.

The Journal of Infection
|April 29, 2015
PubMed
Summary
This summary is machine-generated.

Sepsis is the leading cause of child mortality globally, yet it is often overlooked in global death estimates. Recognizing sepsis as the common endpoint of severe infections is crucial for improving care, especially in resource-limited settings.

Keywords:
ChildrenDiarrheaMalariaPneumoniaSepsis

More Related Videos

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
08:46

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

Published on: August 12, 2020

7.1K
Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
07:30

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Published on: June 15, 2019

10.7K

Related Experiment Videos

Last Updated: Apr 14, 2026

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis
14:54

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis

Published on: January 27, 2019

12.0K
A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
08:46

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

Published on: August 12, 2020

7.1K
Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
07:30

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Published on: June 15, 2019

10.7K

Area of Science:

  • Global Health
  • Pediatric Infectious Diseases
  • Critical Care Medicine

Background:

  • Sepsis is the primary cause of death in children worldwide.
  • Current global mortality estimates often fail to highlight sepsis as the unifying cause of death from various severe infections.
  • Underestimating sepsis impacts the focus and effectiveness of interventions, particularly in resource-limited areas.

Purpose of the Study:

  • To emphasize the critical role of sepsis in global child mortality.
  • To advocate for the recognition of sepsis as a distinct and unifying cause of death.
  • To highlight the importance of sepsis management in resource-limited healthcare settings.

Main Methods:

  • The study reviews global mortality data and emphasizes the common pathway of sepsis in deaths attributed to specific infections.
  • It analyzes the implications of classifying deaths by specific causes versus recognizing the underlying sepsis.
  • The authors discuss the practical challenges and potential benefits of focusing on sepsis in low-resource environments.

Main Results:

  • Sepsis is identified as the leading, yet often underreported, cause of pediatric mortality globally.
  • Classifying deaths solely by primary infection (e.g., pneumonia, malaria) obscures the common critical endpoint of sepsis.
  • Focusing on sepsis and essential interventions can improve care delivery by less specialized healthcare teams.

Conclusions:

  • Recognizing and prioritizing sepsis in global child mortality statistics is essential for accurate assessment and targeted interventions.
  • Highlighting sepsis as the end result of severe infections is critical for improving clinical practice and outcomes, especially in resource-limited settings.
  • Simple, emergency therapeutic interventions for sepsis can be effectively implemented by healthcare providers with limited training, improving survival rates in vulnerable populations.